SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -5.32%3.7B | 2.03%3.57B | -1.18%3.84B | -20.14%15.33B | -11.81%4.04B | -24.53%3.91B | -32.03%3.5B | -9.43%3.89B | 15.59%19.2B | 3.48%4.58B |
Operating revenue | -5.58%3.66B | 1.67%3.52B | -2.65%3.75B | -20.40%15.16B | -12.61%3.97B | -24.61%3.87B | -32.19%3.47B | -9.49%3.85B | 15.61%19.04B | 3.25%4.54B |
Cost of revenue | -18.06%1.61B | 1.51%1.55B | -4.83%1.69B | -37.17%7.19B | -23.90%1.91B | -39.84%1.97B | -52.63%1.53B | -26.81%1.78B | 32.60%11.44B | -0.55%2.52B |
Gross profit | 7.57%2.09B | 2.43%2.02B | 1.90%2.15B | 4.99%8.15B | 2.91%2.12B | 1.68%1.94B | 2.49%1.97B | 13.27%2.11B | -2.79%7.76B | 8.86%2.06B |
Operating expense | 6.56%1.07B | 7.53%1.03B | 4.70%957M | 4.62%3.9B | 6.24%1.02B | 1.93%1.01B | 2.80%956M | 7.91%914M | 8.25%3.73B | 4.11%962M |
Selling and administrative expenses | 8.64%176M | 5.92%179M | 5.42%175M | 4.87%668M | 2.40%171M | 0.00%162M | 11.18%169M | 6.41%166M | -2.75%637M | 1.21%167M |
-General and administrative expense | 8.64%176M | 5.92%179M | 5.42%175M | 4.87%668M | 2.40%171M | 0.00%162M | 11.18%169M | 6.41%166M | -2.75%637M | 1.21%167M |
Other taxes | 0.94%107M | 5.83%109M | 0.91%111M | -4.54%421M | 0.99%102M | -6.19%106M | -11.21%103M | -0.90%110M | 3.52%441M | -0.98%101M |
Other operating expenses | ---1M | 0.00%-1M | -800.00%-9M | 128.57%2M | 500.00%4M | ---- | 0.00%-1M | 80.00%-1M | 0.00%-7M | 0.00%-1M |
Operating profit | 8.66%1.02B | -2.36%993M | -0.25%1.19B | 5.33%4.25B | 0.00%1.1B | 1.41%935M | 2.21%1.02B | 17.75%1.19B | -11.17%4.03B | 13.37%1.1B |
Net non-operating interest income expense | -1.97%-466M | -4.74%-464M | -6.07%-472M | -18.77%-1.8B | -6.10%-452M | -14.54%-457M | -24.79%-443M | -33.63%-445M | -1.41%-1.51B | -15.14%-426M |
Total other finance cost | 1.97%466M | 4.74%464M | 6.07%472M | 18.77%1.8B | 6.10%452M | 14.54%457M | 24.79%443M | 33.63%445M | 1.41%1.51B | 15.14%426M |
Other net income (expense) | -3.60%214M | 18.14%241M | 75.33%263M | -7.98%750M | -19.07%174M | 7.77%222M | 3.55%204M | -23.86%150M | 198.31%815M | 24.28%215M |
Earnings from equity interest | -7.87%199M | 3.17%195M | 56.08%231M | 6.04%772M | -0.90%219M | 22.73%216M | 15.95%189M | -11.90%148M | 41.91%728M | 24.86%221M |
Special income (charges) | -133.33%-1M | 246.15%45M | --32M | -53.13%15M | -150.00%-1M | -66.67%3M | 18.18%13M | --0 | 101.97%32M | 109.09%2M |
-Gain on sale of business | -133.33%-1M | 246.15%45M | --32M | -53.13%15M | -150.00%-1M | -66.67%3M | 18.18%13M | --0 | 101.97%32M | 109.09%2M |
Other non- operating income (expenses) | 433.33%16M | -50.00%1M | ---- | -167.27%-37M | -450.00%-44M | -85.71%3M | -91.30%2M | -89.47%2M | -80.50%55M | -144.44%-8M |
Income before tax | 9.14%764M | -1.03%770M | 9.23%982M | -4.02%3.2B | -7.52%824M | -3.98%700M | -7.05%778M | 2.39%899M | 50.29%3.34B | 14.97%891M |
Income tax | -22.07%113M | 0.00%168M | 6.63%209M | 0.70%715M | 4.04%206M | 8.21%145M | -8.70%168M | 1.03%196M | 92.41%710M | 63.64%198M |
Net income | 17.30%651M | -1.31%602M | 9.96%773M | -5.30%2.49B | -10.82%618M | -6.72%555M | -6.58%610M | 2.78%703M | 41.89%2.63B | 5.96%693M |
Net income continuous Operations | 17.30%651M | -1.31%602M | 9.96%773M | -5.30%2.49B | -10.82%618M | -6.72%555M | -6.58%610M | 2.78%703M | 41.89%2.63B | 5.96%693M |
Minority interest income | 13.04%26M | 12.50%27M | 12.50%27M | 23.38%95M | 4.35%24M | 21.05%23M | 33.33%24M | 41.18%24M | 16.67%77M | 35.29%23M |
Net income attributable to the parent company | 17.48%625M | -1.88%575M | 9.87%746M | -6.16%2.39B | -11.34%594M | -7.64%532M | -7.72%586M | 1.80%679M | 42.83%2.55B | 5.18%670M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | 0.00%4M | -25.00%3M | 0.00%4M | 7.69%14M | -25.00%3M | 0.00%4M | 100.00%4M | 0.00%4M | -7.14%13M | 0.00%4M |
Net income attributable to common stockholders | 17.61%621M | -1.72%572M | 9.93%742M | -6.23%2.38B | -11.26%591M | -7.69%528M | -8.06%582M | 1.81%675M | 43.22%2.54B | 5.21%666M |
Basic earnings per share | 16.67%0.28 | 0.00%0.26 | 10.00%0.33 | -5.36%1.06 | -10.00%0.27 | -4.00%0.24 | -7.14%0.26 | 3.45%0.3 | 43.59%1.12 | 7.14%0.3 |
Diluted earnings per share | 16.67%0.28 | 0.00%0.26 | 10.00%0.33 | -5.36%1.06 | -10.00%0.27 | -4.00%0.24 | -7.14%0.26 | 3.45%0.3 | 43.59%1.12 | 7.14%0.3 |
Dividend per share | 1.77%0.2875 | 1.77%0.2875 | 1.80%0.2825 | 2.04%1.125 | 1.80%0.2825 | 1.80%0.2825 | 1.80%0.2825 | 2.78%0.2775 | 2.80%1.1025 | 2.78%0.2775 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |